Food and Drug Administration (FDA) for reducing cardiovascular and kidney disease risk after a major study showed significantly lower rates of heart attack and stroke among people with type 2 diabetes and established atherosclerosis
Semaglutide (Wegovy, Ozempic, and Rybelsus) Semaglutide is in a category of prescription drugs called glucagon-like peptide-1 agonists, or GLP-1s, and they have upended the way obesity is treated
Humana is the CMS-selected central processor for the entire Bridge program
While GLP-1 medications dominate headlines, what many people dont realize is that GLP-1 is a hormone your body already makes
IDF Diabetes Atlas, 10th ed
A composite example from my practice: Ive cared for a patient maximized on both a DMARD and a biologic, still flaring several times a month, exhausted, in pain